On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 6, 2003, Pages 593-598

  Edlund, Måns ^a   Blombäck, Margareta ^a   He, Shu ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood coagulation disorders; Desmopressin; Fibrinolysis; Menorrhagia; Menstruation

Indexed keywords

DESMOPRESSIN;

ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EVALUATION; FEMALE; FIBRINOLYSIS; HUMAN; MENORRHAGIA; MENSTRUATION; PRIORITY JOURNAL; UTERINE CERVIX;

ADMINISTRATION, INHALATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; DEAMINO ARGININE VASOPRESSIN; FEMALE; FIBRINOLYSIS; HEMORRHAGE; HUMANS; MENORRHAGIA; MENSTRUATION; PLASMIN;

EID: 0042833028     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200309000-00012     Document Type: Article

References (44)

1. Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Acta Obstet Gynecol Scand 1966; 45:25-56.
2. van Eijkeren MA, Christiaens GH, Scholten PC, Sixma JJ. Menorrhagia. Current drug treatment concepts. Drugs 1992; 43:201-209.
3. Cole SK, Billewicz X, Thompson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw 1971; 78:933-939.
4. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995; 85:977-982.
5. Janssen CA, Scholten PC, Heintz AP. Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid? Eur J Obstet Gynecol Reprod Biol 1998; 78:69-72.
6. Rybo G. Clinical and experimental studies on menstrual blood loss. Acta Obstet Gynecol Scand 1966; 45:1-23.
7. Rybo G. Physiological causes of iron deficiency in women: menstruation and pregnancy. Clin Haematol 1973; 2:269-290.
8. Casslén B, Åstedt B. Occurance of both urokinase and tissue plasminogen activator in the human endometrium. Contraception 1983; 28:553-564.
9. Hefnawi F, Saleh A, Kandil O, El-Sheikha Z, Askalani H. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200). Int J Gynaecol Obstet 1979; 16:400-407.
10. Casslén B, Ȧstedt B. Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 1981; 60:55-58.
11. Bonnar J, Sheppard BL, Dockeray CJ. The haemostatic system and dysfunctional uterine bleeding. Res Clin Forum 1983; 5:27-36.
12. Gleeson NC, Buggy F, Sheppard BL, Bonnar J. The effect of tranexamic acid on measured menstrual blood loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand 1994; 73:274-277.
13. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989; 16:221-235.
14. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symtomatology and management. Fertil Steril 1981; 36:433-445.
15. Fraser IS, Hysteroscopy and laparoscopy in women with menorrhagia. Am J Obstet Gynecol 1992; 162:1264-1269.
16. Winkler UH. Menstruation: extravascular fibrinolytic activity and reduced fibrinolytic capacity. Ann NY Acad Sci 1992; 667:289-290.
17. Hahn L, Cederblad G, Rybo G, Pehrsson NG, Bengtsen KK. Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss. Br J Obstet Gynaecol 1976; 83:974-980.
18. Rybo G. Plasminogen activators in the endometrium. Acta Obstet Gynecol Scand 1966; 45:429-438.
19. Gleeson NC, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol 1993; 100:768-771.
20. Lethagen S, Harris AS, Sjörin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: effect on FVIII/vWF, pharmacokinetics and reproducability. Thromb Haemost 1987; 58:1033-1036.
21. Edlund M, Blomback M, Fried G. Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time. Blood Coagul Fibrinolysis 2002; 13:225-231.
22. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964; 16:244-248.
23. Mielke CH, Kaneshiro MM, Maher JA, Weiner JM, Rapaport SJ. The standardized normal bleeding time and its prolongation by aspirin. Blood 1969; 34:204-215.
24. Silveira AMV, Yamahoto T, Adamsson L, Hessel B, Blombäck B. Application of an enzyme-linked immuno-sorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives. Thromb Res 1986; 43:91-102.
25. Rosén S, Andersson M, Blombäck M, Hägglund U, Larrieu MJ, Wolf M, et al. Clinical applications of a chromogenic substrate method for determination of factor VIII activity. Thromb Haemost 1985; 54:818-823.
26. Lämmle B, Eichlisberger R, Marbet GA, Duckert F. Amidolytic activity in normal human plasma assessed with chromogenic substrates. Thromb Res 1979; 16:245-254.
27. Norén I, Ramström G, Wallén P. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma. Haemostasis 1975; 4:110-124.
28. Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A. Outcomes of referrals to gynaecology out-patients clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 1991; 98:789-796.
29. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53:234-238.
30. Kadir RA, Economides DL, Sabin AS, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351:485-489.
31. Dilley A, Drews-Botsch C, Miller C, Lally C, Austin H, Ramaswamy D, et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001; 97:630-636.
32. Kouides P. Menorrhagia from a haematologists point of view. Part I: initial evaluation. Haemophilia 2002; 8:330-338.
33. Woo YL, White B, Corbally R, Byrne M, O'Connell N, O'Shea E, et al. von Willebrand's disease: an important cause of dysfunctional bleeding. Blood Coagul Fibrinolysis 2002; 13:89-93.
34. MtGomery R. In: Colman RW (editor): Hemostasis and thrombosis, 4th edition. Philadelphia: Lippincott Williams & Wilkins; 1998, pp. 263.
35. Cash JD, Gader AMA, Da Costa J. The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, AT III and OT in man. Br J Haematol 1974; 27:363-364.
36. Mannucci PM, Åberg M, Nilsson IM, Robertsson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30:81-93.
37. Peter FW, Benkovic C, Muehlberger T, Vogt PM, Homann HH, Kuhnen C, et al. Effects of desmopressin on thrombogenesis in aspirin-induced platelet dysfunction. Br J Haematol 2002; 117:658-663.
38. Harris AS, Ohlin M, Lethagen S, Nilsson IM. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci 1988; 77:337-339.
39. Lethagen S, Harris AS, Nilsson IM. Intranasal desmopressin (DDAVP) by spray in mild haemophilia A and von Willebrand's disease type I. Blut 1990; 60:187-191.
40. Blombäck M. Mild blödningssjukdom - ett inte ovanligt tillstånd. In: Blombäck M (editor): Koagulationsnytt. Stockholm: Natur och Kultur; 2002, pp. 29-32.
41. Critchley HO, Kelly RW, Brenner RM, Baird DT. The endocrinology of menstruation - a role for the immune system. Clin Endocrinol (Oxford) 2001; 55:701-710.
42. Kelly RW, King AE, Critchley HO. Inflammatory mediators and endometrial function - focus on the perivascular cell. J Reprod Immunol 2002; 57:81-93.
43. Kelly RW, King AE, Critchley HO. Cytokine control in human endometrium. Reproduction 2001; 121:3-19.
44. Cornet PB, Picquet C, Lemoine P, Osteen KG, Bruner-Tran KL, Tabibzadeh S, et al. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloprotineases. J Biol Chem 2002; 277:42496-42504.